How a Dutch Startup's AI Agent Is Transforming Hearing Care

Jan de Vries · 2026-08-28

You know that feeling when a brilliant idea comes from a place you might not expect? That's exactly what's happening in Maastricht, a historic Dutch city. A startup called Clementine just raised $2 million in Seed funding, and they're using it to tackle one of healthcare's quietest, yet most pervasive, problems. It's not about flashy new hardware. Instead, they've built an AI-powered platform designed for hearing clinics. Their core mission? To help those clinics turn inquiries into actual patients. In a world drowning in digital leads but starving for genuine connection, that's a pretty smart angle. ### The Backing and The Vision The $2 million round was led by Healthy.Capital, an Amsterdam-based investor with a sharp eye for early-stage HealthTech. They've backed companies like Pharmi and OpenUp, so they know what they're looking for. Douwe Jippes, managing partner at Healthy.Capital, put it perfectly: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with hearing healthcare." That last part is key. It's not just about scaling a business; it's about scaling impact. And in the hearing care space, the need for impact is enormous. ### Meet Matthew: The AI Hearing Care Agent So, what did they build? The platform revolves around "Matthew," Clementine's AI hearing care agent. Think of Matthew as a compassionate, infinitely patient first point of contact. He engages directly with people who might be considering hearing help. Here's what makes Matthew different: - He's available 24/7, no judgment, no waiting list. - He educates users and helps them overcome both emotional and practical barriers. - He guides them toward the appropriate next steps in their care journey. For a clinic, this is a game-changer. Staff get relief from administrative overload, and more calls reliably turn into booked appointments. For patients, it means clearer communication and, ultimately, better hearing outcomes. "Clinics don't need more leads; they need better conversations at the right moment," says Vince van de Weijer, Clementine's founder and CEO. "Matthew ensures no patient inquiry goes unanswered." ### The Massive Problem They're Solving Let's talk scale for a second. The numbers around hearing loss are staggering. - It affects roughly 1.5 billion people worldwide. - Nearly 80% of those people never seek treatment. - Those who do seek help often wait more than eight years to do so. Eight years. That's a long time to miss out on conversations, music, and connection. Clementine's approach is to use AI blended with behavioral science. They want to create a judgment-free, always-available starting point for care, long before someone is ready to walk into a physical clinic. ### What's Next for Clementine? This funding isn't happening in a vacuum. It comes right after Clementine expanded its reach through a partnership with Zoolstra, a marketing agency serving hearing clinics across the United States and Canada. That's a significant foothold in a massive market. The new capital has a clear purpose: to deepen the AI's capabilities and forge more partnerships. They're looking beyond just hearing clinics to optical retailers and other healthcare organizations, building a wider net to catch people earlier in their journey. It's a fascinating case study. A European startup, leveraging deep technology not to replace human care, but to bridge the gap to it. They're addressing the inertia that keeps millions from getting help, and they're doing it with a conversational AI agent named Matthew. In the bustling world of health tech, that's a voice worth listening to.